Currently predicting for Thu, 4 Jun 2026

ARVN Prediction Chart

ARVN Predictions History

Latest community submissions for ARVN.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 29, 2025 $11.92 -1.96% $11.90 V 99.82% 6
Dec 29, 2025 $12.01 -1.23% $11.90 V 99.07% 2
Dec 29, 2025 Bullish $11.90 X 0
Oct 31, 2025 $9.74 -1.88% $10.14 X 96.09% 0
Oct 31, 2025 $9.81 -1.18% $10.14 X 96.78% 0
Oct 31, 2025 Bullish $10.14 V 1
JS JS Pro
Feb 8, 2022 $72.11 +1.12% $71.49 V 99.13% 3
Feb 8, 2022 Bullish $71.49 V 1
Sep 27, 2019 $24.49 +7.65% $22.75 X 92.35% 0
Sep 24, 2019 $24.69 +4.31% $23.67 X 95.69% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ARVN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ARVINAS INC.
Arvinas
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE